About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Clinical Updates in HER2+ mBC with ASCO coverage
Clinical Updates in HER2+ mBC with ASCO coverage
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
J
Expert Panel Discussion on HER2+ MBC: What Are the RT Options for Brain Mets?
By
Virtual Evolution: A Conference for Women by Women
FEATURING
Jennifer Crozier
,
Mayra Lima
,
Reshma L. Mahtani
,
Kristina Mirabeau-Beale
,
Maria Rueda-Lara
By
Virtual Evolution: A Conference for Women by Women
FEATURING
Jennifer Crozier
,
Mayra Lima
,
Reshma L. Mahtani
,
Kristina Mirabeau-Beale
,
Maria Rueda-Lara
300 views
December 8, 2020
0 Comments
Login to view comments.
Click here to Login
Clinical Updates in HER2+ mBC with ASCO coverage
05:41
Alicia Okines
2021 ASCO Updated Results of HER2CLIMB Study: Tucatinib vs. Placebo …
20:20
Penn Medicine Abramson Cancer Center
2021 Penn Medicine HER2+ MBC Updates
Feat.
S. Bhattacharya
11:06
Total Health
Advances in HER2+ MBC: Management of CNS Metastases
Feat.
T. Traina,
L. Carey
09:00
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
Overview of Available Treatment Options in HER2+ MBC: Tucatinib Comb…
Feat.
J. Abraham
17:39
Virtual West Oncology Conference
2021 Update on Breast Cancer Brain Metastases: Current Treatment Opt…
Feat.
L. Schwartzberg
14:39
University of Kansas Cancer Center Post San Antonio Review
What's New in HER2+ MBC Targeted Therapy: Efficacy Analysis of …
Feat.
H. McArthur
07:59
Azadeh Nasrazadani
Current Data on the Reduction in Risk of Developing New Brain Lesion…
06:50
Akshjot Puri
2021 ASCO Updates on Systemic Chemotherapy in Patients With Brain On…
07:27
Jennifer Plichta
2021 ASCO Highlights on the Survival Among Patients With Untreated M…
19:16
Sarah Sammons
2021 ASCO Update: Impact of Extracranial Disease Status on Survival …
07:12
Rachel Wuerstlein
ASCO 2021 Updates on the Safety of T-DM1 in Patients With HER2+ Loca…
10:50
University of Colorado Cancer Center
Surveying Efficacy Data of Tucatinib, Palbociclib and Letrozole Comb…
Feat.
E. Shagisultanova
05:23
Virtual Evolution: A Conference for Women by Women
Expert Panel Discussion on HER2+ MBC: What Are the RT Options for Br…
Feat.
J. Crozier,
M. Lima,
R. L. Mahtani,
K. Mirabeau-Beale,
M. Rueda-Lara
18:14
University of Colorado Cancer Center
Overview of HR+/HER2+ BC: Prevalence in the US, Subtypes, and Design…
Feat.
E. Shagisultanova
24:44
Total Health
HER2+ BC Panel Discussion: Advances in Treatment and Sequencing of T…
Feat.
L. Kennedy,
B. Patterson,
J. Petruney
